Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 9OD8ISS64U

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interleukin-6 receptor alpha subunit inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Arthritis, Rheumatoid 2 D001172 ClinicalTrials
Lupus Erythematosus, Systemic 2 D008180 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL3833343
FDA SRS 9OD8ISS64U